Lithium diagnostic assay may display falsely elevated results on Atellica CH analyzer
The Atellica CH Lithium_2 diagnostic assay may produce falsely elevated lithium readings on the Atellica CH 930 analyzer, potentially leading to incorrect medication dosage adjustments. No illnesses have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II medical device recall with potential to cause harm through inaccurate treatment decisions. No illnesses or injuries have been reported, and the hazard is described as potential rather than confirmed, which per the rubric qualifies this as High (3).
Plain-English summary
Siemens Healthcare Diagnostics has recalled the Atellica CH Lithium_2 (LITH_2) in vitro diagnostic assay (Material Number 11532401), which measures lithium levels in patient blood samples on the Atellica CH 930 analyzer.
The assay has a potential to produce falsely elevated lithium readings. In the worst case, this could result in erroneously elevated lithium patient results, which may lead healthcare providers to make inappropriate medication dosage adjustments. No illnesses or injuries have been reported in connection with this issue.
The recall affects 1,342 units distributed in the United States and 2,266 units distributed outside the United States. The affected lot numbers are: 110238 (expiring 10/18/22), 110302 (expiring 12/13/22), and 120017 (expiring 4/18/23). Healthcare facilities currently using this assay should verify their lot numbers against the recall information and contact Siemens directly for remediation guidance.
The recalled product
- Product
- Atellica CH Lithium_2 (LITH_2), Siemens Material Number 11532401. in vitro diagnostic assay
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Hazard
- measurement-error
- dosing-error
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereMedline Convenience Kits with Syringes Recalled for Unapproved Design Changes
FDA (Devices) · 2026-07-01
- HighMedline Industries Polycarbonate Syringes Convenience Kits Design Change Recall
FDA (Devices) · 2026-07-01
- HighStryker Neurovascular INZONE Detachment System battery drain
FDA (Devices) · 2026-07-01
- HighSurgify Halo surgical burr recalled for potential breakage risk
FDA (Devices) · 2026-07-01
- ModerateThuvera Laser Console Software Version 2.2 Recall Notice
FDA (Devices) · 2026-07-01